Shaanxi Meibang Pharmaceutical Group Co Ltd
SSE:605033
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/S
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Valuation Scenarios
If P/S returns to its 3-Year Average (3.1), the stock would be worth ¥19.9 (13% downside from current price).
| Scenario | P/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 3.6 | ¥22.95 |
0%
|
| 3-Year Average | 3.1 | ¥19.9 |
-13%
|
| 5-Year Average | 3 | ¥19.32 |
-16%
|
| Industry Average | 2.6 | ¥16.77 |
-27%
|
| Country Average | 2.8 | ¥17.66 |
-23%
|
Forward P/S
Today’s price vs future revenue
Peer Comparison
| Market Cap | P/S | P/E | ||||
|---|---|---|---|---|---|---|
| CN |
S
|
Shaanxi Meibang Pharmaceutical Group Co Ltd
SSE:605033
|
3.1B CNY | 3.6 | 138.5 | |
| US |
|
Corteva Inc
NYSE:CTVA
|
53.3B USD | 3.1 | 49.6 | |
| CA |
|
Nutrien Ltd
TSX:NTR
|
48.9B CAD | 1.3 | 15.9 | |
| CN |
|
Qinghai Salt Lake Industry Co Ltd
SZSE:000792
|
209B CNY | 13.5 | 24.7 | |
| CL |
|
Sociedad Quimica y Minera de Chile SA
NYSE:SQM
|
26B USD | 5.8 | 45 | |
| CN |
|
Zangge Mining Co Ltd
SZSE:000408
|
142.9B CNY | 38.1 | 30.5 | |
| US |
|
CF Industries Holdings Inc
NYSE:CF
|
19.5B USD | 2.7 | 13.2 | |
| NO |
|
Yara International ASA
OSE:YAR
|
135.6B NOK | 0.9 | 10.6 | |
| SA |
|
SABIC Agri-Nutrients Company SJSC
SAU:2020
|
53.8B SAR | 4.1 | 12.4 | |
| CN |
|
Shandong Hualu-Hengsheng Chemical Co Ltd
SSE:600426
|
83.2B CNY | 2.6 | 22.3 | |
| RU |
|
PhosAgro PAO
MOEX:PHOR
|
869.1B RUB | 1.5 | 7.5 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.5 |
| Median | 2.8 |
| 70th Percentile | 5.4 |
| Max | 5 034 353.9 |
Other Multiples
Shaanxi Meibang Pharmaceutical Group Co Ltd
Glance View
Shaanxi Meibang Pharmaceutical Group Co., Ltd. engages in the research, development, production, and sale of pesticide preparations. The company is headquartered in Xi'An, Shaanxi and currently employs 933 full-time employees. The company went IPO on 2021-09-16. The firm's products mainly include fungicides and pesticides. The fungicides include 80% dimethylmorpholine water dispersible granules, 27% chunleimycin bromonitrile wettable powder, 72% pyrazole ether ester combined water dispersible granules, 22% chunleimycin chlorobromoisocyanuric acid wettable powder, etc. The insecticides include 21% abamectin benzoate fenitrile suspension, 22% thiamethoxam beta cypermethrin suspension, 45% biphenyl hydrazide ethiconazole suspension, 20% fenitrile bifenthrin suspension, etc.
